Comments
Loading...
Viracta Therapeutics (VIRX) Forecast
NewsEarningsViracta Therapeutics (VIRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestViracta Therapeutics (NASDAQ:VIRX) Stock Quotes, Forecast and News Summary
Viracta Therapeutics Stock (NASDAQ: VIRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Viracta Therapeutics (VIRX) stock?
You can purchase shares of Viracta Therapeutics (NASDAQ:VIRX) through any online brokerage.
Who are Viracta Therapeutics (VIRX) competitors?
Other companies in Viracta Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN), Coeptis Therapeutics (NASDAQ:COEP) and ABVC BioPharma (NASDAQ:ABVC).
What is the forecast, or price target, for Viracta Therapeutics (VIRX) stock?
Viracta Therapeutics has a consensus price target of $5.83.
What is the current price for Viracta Therapeutics (VIRX)?
The stock price for Viracta Therapeutics (NASDAQ: VIRX) is $0.1472 last updated December 3, 2024 at 11:57 AM EST.
Does Viracta Therapeutics (VIRX) pay a dividend?
There are no upcoming dividends for Viracta Therapeutics.
When is Viracta Therapeutics (NASDAQ:VIRX) reporting earnings?
Viracta Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Viracta Therapeutics (VIRX) going to split?
There is no upcoming split for Viracta Therapeutics.
What sector and industry does Viracta Therapeutics (VIRX) operate in?
Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.